HighTower Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$451K Buy
8,450
+1,229
+17% +$65.6K ﹤0.01% 2599
2025
Q1
$292K Buy
+7,221
New +$292K ﹤0.01% 2870